Results 91 to 100 of about 36,851 (264)

SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults

open access: yesEuropean Journal of Immunology, Volume 56, Issue 1, January 2026.
SARS‐CoV‐2 mRNA vaccination triggers bystander activation of B cells, transiently increasing antibody levels after the first vaccination against influenza, RSV, and tetanus. Reactivation of B cell responses also occurred, where (CD11c+) MBC and DN3 are expanded after SARS‐CoV‐2 mRNA vaccination, independent of antigen exposure.
Lisan H. Kuijper   +23 more
wiley   +1 more source

Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults

open access: yesSão Paulo Medical Journal
BACKGROUND: Live attenuated varicella vaccines for the prevention of varicella (chickenpox) has been demonstrated both in randomised controlled trials (RCTs) and in population-based immunisation programmes in countries such as the United States. However,
Kristine Macartney, Peter McIntyre
doaj   +1 more source

Assessment of varicella vaccine effectiveness in Germany: a time-series approach [PDF]

open access: yes, 2017
A multivariate time-series regression model was developed in order to describe the 2005-2008 age-specific time-course of varicella sentinel surveillance data following the introduction of a varicella childhood vaccination programme in Germany.
BADER, H.-M   +5 more
core  

The Role of Viral and Bacterial Infections in the Etiology of Behçet's Disease

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 1, January 2026.
Bacterial and viral pathogens may play a key role in Behçet's disease (BD) pathogenesis by triggering autoimmunity, molecular mimicry, or microbiome disruption. These infectious agents could initiate inflammatory pathways, contributing to BD's diverse clinical manifestations.
Mohsen Moghoofei   +4 more
wiley   +1 more source

Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy

open access: yesBMC Infectious Diseases, 2018
Background Monovalent varicella vaccines have been available in the Veneto Region of Italy since 2004. In 2006, a single vaccine dose was added to the immunisation calendar for children aged 14 months.
Carlo Giaquinto   +16 more
doaj   +1 more source

Vaccines for prophylaxis of viral infections in patients with hematological malignancies. [PDF]

open access: yes, 2011
Viral infections cause significant morbidity and mortality in patients with hematological malignancies. It remains uncertain whether viral vaccinations in these patients are supported by good evidence.
Chan, GC   +4 more
core   +1 more source

Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics

open access: yesMedComm, Volume 7, Issue 1, January 2026.
This review provides a comprehensive overview of the latest research advances in MPXV, with a focused analysis across five core dimensions: epidemiology, virology, diagnosis, vaccine, and therapeutics. The primary objective of this review is to advance the understanding of MPXV and facilitate the development of more effective diagnostic methods ...
Yunzheng Yan   +14 more
wiley   +1 more source

The Effectiveness of California Assembly Bill 2109: Personal Belief Exemptions for Kindergarten Immunizations [PDF]

open access: yes, 2016
The numbers of vaccine preventable diseases (VPDs) in the United States has declined with the development, administration, and effectiveness of vaccines during the 1970s and 1980s.
Goishi-Bessey, Lilli Shizuka
core   +1 more source

Immunization strategies targeting newly arrived migrants in Non-EU countries of the mediterranean basin and black sea [PDF]

open access: yes, 2017
Background: The World Health Organization recommends that host countries ensure appropriate vaccinations to refugees, asylum seekers and migrants. However, information on vaccination strategies targeting migrants in host countries is limited. Methods: In
Declich, Silvia   +7 more
core   +1 more source

Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial

open access: yesAllergy, Volume 81, Issue 1, Page 209-219, January 2026.
This emulated target trial investigated the risk of developing chronic respiratory diseases (COPD, asthma, and ILD) associated with live zoster vaccination using a nationwide, population‐based cohort of individuals aged ≥ 50 years in South Korea. Live zoster vaccination significantly reduced the risk of COPD, asthma, and ILD, and reduced hospital ...
Tae Hyeon Kim   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy